A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. (Q53378993)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. |
scientific article |
Statements
A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. (English)
Balch CM
Wallack MK
Sivanandham M
Urist MM
Bland KI
Murray D
Robinson WA
Flaherty LE
Richards JM
Bartolucci AA
1 January 1995
75
1
34-42